Celldex 治療公司
US ˙ NasdaqCM ˙ US15117B2025

SecurityCLDX / Celldex Therapeutics, Inc.
InstitutionJefferies Group LLC
Latest Disclosed Ownership0 shares
Latest Disclosed Value $ 0
Jefferies Group LLC ownership in CLDX / Celldex Therapeutics, Inc.

On September 21, 2023 - Jefferies Group LLC filed a 13F-HR/A form disclosing ownership of 0 shares of Celldex Therapeutics, Inc. (US:CLDX) valued at $0 USD as of September 30, 2022. The entity filed a previous 13F-HR/A on September 21, 2023 disclosing 59,098 shares of Celldex Therapeutics, Inc.. This represents a change in shares of -100.00% during the quarter. The current value of the position is $0 USD.

Jefferies Group LLC has a history of taking positions in derivatives of the underlying security (CLDX) in the form of stock options. The firm currently holds call options representing 127,700 of underlying shares valued at $3,589,647 USD and put options representing 16,000 of underlying shares valued at $449,760 USD .

Note: prior versions of this page mistakenly stated that the share values represented the number of options, not the number of underlying shares. For more information on the data backing these reports, please see the SEC document Frequently Asked Questions About Form 13F.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Institutional Put/Call Ratios
(Premium Subscription Required)

In addition to reporting standard equity and debt issues, institutions with more than 100MM assets under management must also disclose their put and call option holdings. Since put options generally indicate negative sentiment, and call options indicate positive sentiment, we can get a sense of the overall institutional sentiment by plotting the ratio of puts to calls. The chart to the right plots the historical put/call ratio for this instrument.

Using Put/Call Ratio as an indicator of investor sentiment overcomes one of the key deficiencies of using total institutional ownership, which is that a significant amount of assets under management are invested passively to track indices. Passively-managed funds do not typically buy options, so the put/call ratio indicator more closely tracks the sentiment of actively-managed funds.

CLDX / Celldex Therapeutics, Inc. Historical Put/Call Ratio
Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2023-09-21 2022-09-30 13F/A-1 CELLDEX THERAPEUTICS INC COM NEW 15117B202 0 -59,098 -100.00 0 -100.00
2022-11-14 2022-09-30 13F CELLDEX THERAPEUTICS INC COM NEW 15117B202 0 -59,098 0
2023-09-21 2022-06-30 13F/A-1 CELLDEX THERAPEUTICS INC COM NEW 15117B202 59,098 54,348 1,144.17 1,593 889.44 0.0132
2022-08-15 2022-06-30 13F CELLDEX THERAPEUTICS INC COM NEW 15117B202 59,098 54,348 1,593 0.0124
2023-09-21 2022-03-31 13F/A-1 CELLDEX THERAPEUTICS INC COM NEW 15117B202 4,750 -2,750 -36.67 162 -44.29 0.0010
2022-05-16 2022-03-31 13F CELLDEX THERAPEUTICS INC COM NEW 15117B202 7,622 -2,252 162 0.0009
2023-09-21 2021-12-31 13F/A-1 CELLDEX THERAPEUTICS INC COM NEW 15117B202 7,500 7,500 290 0.0017
2022-02-14 2021-12-31 13F CELLDEX THERAPEUTICS INC COM NEW 15117B202 9,874 9,874 331 0.0018
2023-09-21 2021-06-30 13F/A-2 CELLDEX THERAPEUTICS INC COM NEW 15117B202 0 -25,637 -100.00 0 -100.00
2021-08-20 2021-06-30 13F/A-1 CELLDEX THERAPEUTICS INC COM NEW 15117B202 0 -25,637 0
2021-08-16 2021-06-30 13F CELLDEX THERAPEUTICS INC COM NEW 15117B202 0 -25,637 0
2023-09-21 2021-03-31 13F/A-1 CELLDEX THERAPEUTICS INC COM NEW 15117B202 25,637 25,637 528 0.0046
2021-05-14 2021-03-31 13F CELLDEX THERAPEUTICS INC COM NEW 15117B202 25,637 25,637 528 0.0046
2018-11-14 2018-09-30 13F CELLDEX THERAPEUTICS INC COM 15117B103 0 -279,320 -100.00 0 -100.00
2018-08-14 2018-06-30 13F CELLDEX THERAPEUTICS INC COM 15117B103 279,320 279,320 141 0.0008
2016-05-11 2016-03-31 13F CELLDEX THERAPEUTICS INC COM 15117B103 0 -14,650 -100.00 0 -100.00
2016-02-12 2015-12-31 13F CELLDEX THERAPEUTICS INC COM 15117B103 14,650 14,650 0.00 230 0.0013
2015-11-13 2015-09-30 13F CELLDEX THERAPEUTICS INC COM 15117B103 0 -42,100 -100.00 0 -100.00
2015-08-18 2015-06-30 13F CELLDEX THERAPEUTICS INC COM 15117B103 42,100 -2,673 -5.97 1,062 -14.90 0.0055
2015-05-18 2015-03-31 13F CELLDEX THERAPEUTICS INC COM 15117B103 44,773 44,773 6.35 1,248 17.51 0.0070
2014-08-14 2014-06-30 13F CELLDEX THERAPEUTICS INC COM 15117B103 0 -64,741 -100.00 0 -100.00
2014-05-16 2014-03-31 13F CELLDEX THERAPEUTICS INC COM 15117B103 64,741 64,741 61,558.10 1,144 57,100.00 0.0111
2013-11-18 2013-09-30 13F CELLDEX THERAPEUTICS INC COM 15117B103 0 -105 -100.00 0 -100.00
2013-08-15 2013-06-30 13F CELLDEX THERAPEUTICS INC COM 15117B103 105 105 2 0.0000
Disclosed Call Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share
Price
Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2023-09-21 2022-09-30 13F/A CELLDEX THERAPEUTICS INC COM NEW Call 127,700 46.44 3,590 52.72 n/a n/a n/a
2022-11-14 2022-09-30 13F CELLDEX THERAPEUTICS INC COM NEW Call 127,700 3,590 n/a n/a n/a
2023-09-21 2022-06-30 13F/A CELLDEX THERAPEUTICS INC COM NEW Call 87,200 8.73 2,351 -13.95 n/a n/a n/a
2022-08-15 2022-06-30 13F CELLDEX THERAPEUTICS INC COM NEW Call 87,200 2,351 n/a n/a n/a
2023-09-21 2022-03-31 13F/A CELLDEX THERAPEUTICS INC COM NEW Call 80,200 -17.74 2,732 -27.50 n/a n/a n/a
2022-05-16 2022-03-31 13F CELLDEX THERAPEUTICS INC COM NEW Call 80,200 2,732 n/a n/a n/a
2023-09-21 2021-12-31 13F/A CELLDEX THERAPEUTICS INC COM NEW Call 97,500 3,767 n/a n/a n/a
2022-02-14 2021-12-31 13F CELLDEX THERAPEUTICS INC COM NEW Call 97,500 3,767 n/a n/a n/a
2023-09-21 2020-12-31 13F/A CELLDEX THERAPEUTICS INC COM NEW Call 0 -100.00 0 -100.00 n/a n/a n/a
2021-02-16 2020-12-31 13F CELLDEX THERAPEUTICS INC COM NEW Call 0 0 n/a n/a n/a
2020-11-13 2020-09-30 13F CELLDEX THERAPEUTICS INC COM NEW Call 20,100 298 n/a n/a n/a
2016-05-11 2016-03-31 13F CELLDEX THERAPEUTICS INC COM Call 0 -100.00 0 -100.00 n/a n/a n/a
2016-02-12 2015-12-31 13F CELLDEX THERAPEUTICS INC COM Call 14,700 0.00 230 n/a n/a n/a
2014-08-14 2014-06-30 13F CELLDEX THERAPEUTICS INC COM Call 0 -100.00 0 -100.00 n/a n/a n/a
2014-05-16 2014-03-31 13F CELLDEX THERAPEUTICS INC COM Call 80,200 122.78 1,417 152.14 n/a n/a n/a
2013-11-18 2013-09-30 13F CELLDEX THERAPEUTICS INC COM Call 0 -100.00 0 -100.00 n/a n/a n/a
2013-08-15 2013-06-30 13F CELLDEX THERAPEUTICS INC COM Call 36,000 562 n/a n/a n/a
Disclosed Put Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share Price Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2023-09-21 2022-09-30 13F/A CELLDEX THERAPEUTICS INC COM NEW Put 16,000 -87.04 450 -86.51 n/a n/a n/a
2022-11-14 2022-09-30 13F CELLDEX THERAPEUTICS INC COM NEW Put 16,000 450 n/a n/a n/a
2023-09-21 2022-06-30 13F/A CELLDEX THERAPEUTICS INC COM NEW Put 123,500 671.88 3,330 511.95 n/a n/a n/a
2022-08-15 2022-06-30 13F CELLDEX THERAPEUTICS INC COM NEW Put 123,500 3,330 n/a n/a n/a
2023-09-21 2022-03-31 13F/A CELLDEX THERAPEUTICS INC COM NEW Put 16,000 -60.00 545 -64.79 n/a n/a n/a
2022-05-16 2022-03-31 13F CELLDEX THERAPEUTICS INC COM NEW Put 16,000 545 n/a n/a n/a
2023-09-21 2021-12-31 13F/A CELLDEX THERAPEUTICS INC COM NEW Put 40,000 66.67 1,546 19.31 n/a n/a n/a
2022-02-14 2021-12-31 13F CELLDEX THERAPEUTICS INC COM NEW Put 40,000 1,546 n/a n/a n/a
2021-12-17 2021-09-30 13F/A CELLDEX THERAPEUTICS INC COM NEW Put 24,000 1,296 n/a n/a n/a
2023-09-21 2021-09-30 13F/A CELLDEX THERAPEUTICS INC COM NEW Put 24,000 1,296 n/a n/a n/a
2021-11-15 2021-09-30 13F CELLDEX THERAPEUTICS INC COM NEW Put 24,000 1,296 n/a n/a n/a
2021-08-20 2021-06-30 13F/A CELLDEX THERAPEUTICS INC COM NEW Put 0 0 n/a n/a n/a
2023-09-21 2021-06-30 13F/A CELLDEX THERAPEUTICS INC COM NEW Put 0 -100.00 0 -100.00 n/a n/a n/a
2021-08-16 2021-06-30 13F CELLDEX THERAPEUTICS INC COM NEW Put 0 0 n/a n/a n/a
2023-09-21 2021-03-31 13F/A CELLDEX THERAPEUTICS INC COM NEW Put 107,000 2,204 n/a n/a n/a
2021-05-14 2021-03-31 13F CELLDEX THERAPEUTICS INC COM NEW Put 107,000 2,204 n/a n/a n/a
2014-08-14 2014-06-30 13F CELLDEX THERAPEUTICS INC COM Put 0 -100.00 0 -100.00 n/a n/a n/a
2014-05-16 2014-03-31 13F CELLDEX THERAPEUTICS INC COM Put 27,500 486 n/a n/a n/a
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.